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Abstract
Advances in retooling microorganisms have enabled bioproduction of ‘drop-in’ biofuels, fuels that 
are compatible with existing spark-ignition, compression-ignition, and gas-turbine engines. As the 
majority of petroleum consumption in the United States consists of gasoline (47%), diesel fuel and 
heating oil (21%), and jet fuel (8%), ‘drop-in’ biofuels that replace these petrochemical sources 
are particularly attractive. In this review, we discuss the application of aldehyde decarbonylases to 
produce gasoline substitutes from fatty acid products, a recently crystallized reductase that could 
hydrogenate jet fuel precursors from terpene synthases, and the exquisite control of polyketide 
synthases to produce biofuels with desired physical properties (e.g., lower freezing points). With 
our increased understanding of biosynthetic logic of metabolic pathways, we discuss the unique 
advantages of fatty acid, terpene, and polyketide synthases for the production of bio-based 
gasoline, diesel and jet fuel.
In 2014, the levels of anthropogenic greenhouse gases (carbon dioxide, methane, and nitrous 
oxide) reached their highest levels in at least 800 000 years [1,2]. Transportation vehicles 
contributed approximately 14% of all global greenhouse gas emissions in 2010, with 95% of 
that derived from petroleum based fuels [3]. If fuels produced from renewable sources such 
as biomass, landfill gas or atmospheric CO2 replaced petrochemically-derived fuels, it would 
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reduce CO2 emissions through the ‘closed CO2 cycle’: CO2 that is burned through 
combustion is reused from the atmosphere to produce the biofuel [4]. While no current 
biofuel should not be considered purely carbon neutral after accounting for collateral 
emissions, the production of ‘drop-in’ biofuels, fuels that are compatible with existing 
spark-ignition, compression-ignition and gas-turbine engines, could greatly reduce 
greenhouse gas emissions [5,6].
Microbial fermentation is a particularly attractive means of producing renewable biofuels. 
Genetically engineered microbes can utilize feedstocks from non-agricultural sources (e.g., 
switchgrass) that does not compete with food crops for land mass to produce various fuels 
and commodity chemicals. In this review, we discuss the microbial production of biofuels 
derived from three different classes of biosynthetic pathways: fatty acid, isoprenoid, and 
polyketide. Short chain alcohols (e.g., isobutanol, 1-butanol) are an important class of drop-
in fuels, and will continue to be in the future. As they are produced from different pathways 
and are well reviewed [7], we exclude their discussion here. We provide the maximum 
theoretical mass yield and highest reported titers for these select ‘drop-in’ biofuels (Table 1) 
and discuss the production pathways. Fatty acid biosynthesis is the most well-established 
pathway to produce biofuels, and we discuss the recent work to synthesize short and 
medium chain alkanes as constituents of gasoline and diesel. Isoprenoid hydrocarbons often 
contain branching and ring structures that have high energy content, low water miscibility 
and reduced premature ignition, rendering them attractive biofuel substitutes for diesel and 
even jet fuel. Polyketide synthases, although they have been explored less thoroughly for 
such applications, also have attractive biosynthetic logic to produce high performance 
biofuels.
Biofuels derived from fatty acid biosynthetic pathways
While the fatty acid pathway has been leveraged to produce alcohol, ketone, ester and olefin 
biofuel products [8–10], there is an exciting new avenue to synthesize short chain and 
medium chain alkanes that could be used in place of gasoline and diesel. Initiated by acetyl-
CoA, fatty acid biosynthesis in Escherichia coli is performed by the fatty acid synthase 
complex (FAS) II that uses multiple, discrete enzymes to generate a saturated fatty acid 
(typically 14–18 carbons in length). Alkanes could be produced from the products of FAS 
(fatty-acyl carrier protein (ACP), free fatty acid, and fatty-acyl-CoA (Figure 1a) using a fatty 
aldehyde decarbonylase (ADO), first identified in the cyanobacterium Synechococcus 
elongatus, which converts fatty aldehydes to alkanes [11].
In a seminal report, Schirme et al. demonstrated that an acyl carrier protein reductase (AAR) 
could produce fatty aldehydes directly from fatty acyl-ACPs in E. coli (Figure 1b) [11]. With 
the heterologous expression of an improved ADO from Nostoc punctiforme, 300 mg/L of 
odd-numbered C13–C17 hydrocarbons were produced, 80% present extracellularly. A 
subsequent report demonstrated an AAR from Bacillus subtilis could produce even-
numbered C14 and C16 when expressed with ADO [12]. While this method is appropriate 
for diesel fuel type molecules, the limitations in the chain-length profile of hydrocarbons 
synthesized precludes producing a substitute for gasoline, which is a blend of short-chain 
hydrocarbons (typically three to nine carbons) [13].
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There are several advantages to producing alkanes from FFAs or acyl-CoA: fatty acids have 
been produced in higher abundance than fatty acyl-ACPs, production from fatty acids 
affords better control over chain length, and the pool of fatty acids can be manipulated 
[9,14,15]. A recent study described the in vivo production of a modified acyl-ACP 
thioesterase to produce short-chain fatty acids, which were then appended to CoA via an 
overexpressed fatty-acyl-CoA ligase (Figure 1b). The cells produced 580 mg/L of short 
chain alkanes from fatty-acyl-CoAs by the sequential reaction of Clostridium 
acetobutylicum fatty acyl-CoA reductase (ACR1) and Arabidopsis thaliana ADO [16]. As 
such, this strategy relied on expressing an acyl-ACP thioesterase to terminate FAS at the 
desired chain length. Howard and coworkers used a similar approach with heterologous 
thioesterases and branched FFAs in E. coli generating branched alkanes [17]. Eschewing 
heterologous thioesterases, Liu et al. engineered ACPs that prefer particular fatty acid chain 
lengths that can generate predictable alterations to the hydrocarbon cellular output [18]. 
While production of biofuels from fatty-acyl-CoA has enhanced control over the length of 
hydrocarbon chains produced, this pathway requires the additional processing step of CoA 
ligation compared to production from FFAs.
Recently, a more direct method to generate fatty aldehydes has used a carboxylic acid 
reductase (CAR) from Mycobacterium marinum to directly convert FFAs to fatty aldehydes 
(Figure 1b) [18]. Akhtar et al. demonstrated that this CAR can accept a broad range of 
substrate chain lengths. Furthermore, the CAR route is a more thermodynamically favored 
pathway than the cyanobacterial AAR route (−35.9 kJ/mol compared to −3.9 kJ/mol), and 
has much better in vitro kinetics than both the AAR and ACR1 pathways [19]. In a 
subsequent study, Kallio et al. used a thioesterase specific for butyryl-ACP to tune the FFA 
pool, which the CAR converted to generate short chain alkanes, producing 32 mg/L of 
propane in a shake flask fermentation [20••].
While biofuel production of alkanes is dependent on titers of FFAs, biofuel yields are much 
lower than the yields of FFAs due to factors including intermediate and product toxicity, 
specificity, and catalytic efficiency of the enzymatic machinery. Flux may also be inhibited 
by intracellular precursor supply, as FFAs are secreted by overexpressing strains [21]. The 
highest published titers of FFAs (8.6 g/L) have been achieved through modular optimization 
of fatty acid production followed by fed-batch fermentation [22]; however titers of biofuels 
generated from this process are much lower. As acyl-ACPs inhibit several enzymes of the 
endogenous Type II FAS in E. coli, a promising strategy could involve a parallel system of 
heterologous type I FAS systems [8,23•].
Currently the limiting factor in alkane production is ADO catalytic activity, an obstacle that 
is compounded by native aldehyde reductases (AHR) (Figure 1c) [10]. AHR seemingly 
competes with aldehyde decarbonylases for fatty aldehydes that result in the production of 
alcohols instead of alkanes (Figure 1) [24]. While removing competing AHR can increase 
flux to alkanes [25,26], recent work showed that moderate fatty alcohol production 
stimulated alkane biosynthetic flux, and when combined with other metabolic engineering 
improvements, 1.26 g/L in a fed-batch fermentation of alkanes was achieved [27••], the 
highest titer reported. As O2 and electron supply are co-substrates for the conversion of 
aldehydes to alkanes in this class of decarbonylases [28], an optimized electron transfer 
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system can increase the catalytic rate of ADO [20••,27••]. While challenges remain in 
microbial production of alkanes through FASs, particularly in kinetic throughput, it is 
currently the most mature pathway for bioproduction of straight-chain hydrocarbons of short 
to medium chain length that compose gasoline and diesel.
Isoprenoid based biofuel production
The isoprenoid pathway, which elongates carbon skeleton chains through the five-carbon 
units by condensing the building blocks isopentenyl pyrophosphate (IPP) and dimethylallyl 
pyrophosphate (DMAPP), has attracted great interest as a biofuel production platform. 
While bacteria can produce IPP through the methylerythitol-4-phosphate (MEP) pathway, a 
mevalonate-based (MVA) pathway has been reconstituted in E. coli, which greatly improves 
the flux to IPP (Figure 2a) [29,30]. Monoter-penes (C10), produced by the condensation of 
IPP and DMAPP, and sesquiterpenes (C15), produced from the condensation of two IPPs 
and one DMAPP, in particular have been identified as diesel and jet fuel substitutes. A 
terpene synthase converts the precursor to the final compound, which, following 
modification via hydrogenation or dimerization, is a suitable biofuel.
Bisabolene and farnesene are two desirable biodiesel precursors synthesized from farnesyl 
pyrophosphate (FPP) using bisabolene synthase (BS) and farnesene synthase (FS), 
respectively (Figure 2b). When chemically hydrogenated, bisabolane has similar fuel 
properties to D2 diesel fuel [31]. Bisabolene has been produced in E. coli and 
Saccharomyces cerevisiae at titers higher than 900 mg/L in shake flasks [32] and 5.2 g/L in 
a fermentation process [33]. Demonstrating an exploration of an alternative chassis organism 
that can use uncommon sugars as well as consume lignocellulosic biomass, our group 
engineered a strain of Streptomyces venezuelae to produce bisabolene at 10 mg/L, which is 
two orders of magnitude higher than the total terpene yield of wild-type S. venezuelae [34]. 
Similar to bisabolane, farnesane has better combustion properties than diesel with similar 
viscosity and density [31]. Farnesene, the dehydrogenated form of farnesane, is well-
tolerated in S. cerevisiae, with yields of 170 mg/L in fed batch fermentations [35]. The 
kinetics of farnesene production were quantified using an in vitro reconstitution system with 
purified components, and using this information, Zhu et al. overexpressed genes encoding 
enzymes in the pathway to yield up to 1.1 g/L of farnesene in E. coli at the shake-flask scale 
[36•]. Farnesene has seen interest from industry as well, and recently Amyris announced a 
record low manufacturing cost of farnesene at $1.75 per liter [37].
While there has been much progress in the production of biodiesel, the development of 
biobased jet fuels to replace high-density, high-energy tactical fuels such as JP-10 and RJ-5 
has lagged. Recently, it has been shown that the chemical dimerization of pinene results in a 
bicyclic terpene with comparable values for density and volumetric heating (0.94 g/mL and 
39.5 MJ/L) as JP-10 [38]. Pinene titers, synthesized from GPP with a pinene synthase 
(Figure 2c), are an order of magnitude lower than those achieved for sesquiterpenes like 
bisabolene, most likely due to flux inhibition by its precursor GPP or toxicity of pinene to E. 
coli [39,40]. Addressing flux inhibition, a recent report found that a GPPS-PS protein fusion 
to relieve inhibition of GPPS by GPP produced 32 mg/L of pinene [38]. To reduce toxicity 
and increase pinene titer, general stress response proteins, heat-shock proteins, or efflux 
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pumps could confer increased resistance. Indeed, a study found that the heterologous 
expression of YceI, a possible transporter protein belonging to the diverse and largely 
uncharacterized family of YceI genes, from Marinobacter aquaeolei increases resistance to 
pinene toxicity in E. coli [41].
The hydrogenated form of limonene, limonane, also has favorable properties for jet-biofuels 
[42,43]. Limonene is produced from the cyclization of GPP by limonene synthase (LS), 
which can be subsequently catalytically hydrogenated to limonane (Figure 2c). Early efforts 
to produce limonene suffered from low intracellular levels of its precursor geranyl 
pyrophosphate in E. coli [44]. Using the heterologous expression system of the MVA 
pathway consisting of GPP synthase, limonene synthase and a cytochrome P450, a recent 
study improved the yield of limonene to 400 mg/L from glucose in shake-flask cultures [43]. 
However, limonene toxicity due to the common oxidation product limonene hydroperoxide 
limits production [45], and a two-phase extractive fermentation can alleviate monoterpene 
toxicity [46]. Using a two liquid-phase fed-batch system, limonene titers reached 700 mg/L 
with glucose as the sole carbon source [46].
Limonene, bisabolene, and farnesene all require chemical hydrogenation after in vivo 
production. This capital cost could be eliminated through a hydrogenation enzyme, and 
recently, a report found that geranylgeranyl reductase (GGR) from Sulfolobus acidocaldarius 
catalyzes the hydrogenation of three out of four double bonds in GPP to produce a near 
saturated alkyl backbone. Natively produced as part of the organism’s unusual isoprenoid-
based cellular membrane, the crystallized structure guided the selection of targeted 
mutations to increase the rate of hydrogenation [47••]. If GGR is further engineered to fully 
and rapidly hydrogenate GPP and FPP, GGR could be beneficial in producing final-state 
biofuel compounds in vivo.
Polyketide-based biofuel production
Polyketide synthases are molecular factories that produce an array of antibiotics, cancer 
therapeutics, and other medicinal compounds. While there are three types of PKSs, Type I 
PKSs are capable of full reductive processing to form saturated carbon skeletons that are 
particularly appealing as biofuels. Type I PKSs are also an attractive engineering target as 
the assembly line formation and rounds of elongation present an easily identifiable 
biosynthetic logic for the tailored production of specific hydrocarbons. A fully reducing 
module consists of the following domains: a ketosynthase (KS), an acyltransferase (AT), a 
dehydratase (DH), a methyltransferase (MT), an enoyl reductase (ER), a ketoreductase 
(KR), an acyl carrier protein (ACP), and a thioesterase (TE) (Figure 3). The versatility and 
tailoring of products by PKSs, along with reprogrammable domains, render PKSs a 
potentially important platform to produce biofuels with desired physical properties. One 
potential challenge that is presented when utilizing PKSs, however, is that they have been 
reported to be catalytically slower than fatty acid synthases. For example, FAS synthesis of 
palmitic acid is completed in less than a second, whereas the DEBS system requires 
approximately 2 min, at least in vitro [48,49]. However, the mechanistic basis of this 
difference in catalytic efficiency is unclear [49], and the measurements of PKS kinetics may 
be retarded by expression (followed by purification, and kinetic characterization) in E. coli, 
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which may be a suboptimal folding environment for this particular class of enzymes [50]. 
Recent experiments in our lab have indicated that in other hosts, in vivo PKS kinetics may 
be closer to FAS kinetics than previously thought (results unpublished).
In the first exploitation of PKSs for biofuel production, Menendez-Bravo et al. diverted the 
FFA pool to an iterative Type I PKS for the production of fatty alcohols and esters. By 
expressing an iterative Mycobacterium tuberculosis PKS that accepts methylmalonyl-CoA 
as a substrate, the group produced 98 mg/L of multi-methyl branched esters in E. coli [51]. 
In a more recent study, Liu et al. expressed the iterative Type I PKS from Streptomyces, 
SgcE, and its cognate thioesterase, SgcE10, in a two-plasmid system in E. coli. The group 
optimized the ratio of SgcE expression to SgcE10 expression, and in a fed-batch 
fermentation followed by chemical hydrogenation, the study reported a yield of 140 mg/L of 
pentadecane [52•]. While these iterative PKS pathways are technically simple and provided a 
starting point for engineering PKS pathways for biofuel production, modular Type I systems 
afford unique opportunities to precisely tailor the chemical structure. In a notable example of 
this versatility, our group recently engineered a chimeric Type I PKS with fully reductive 
processing domains into the first module of borreledin PKS, enabling the bio-based 
production of the commodity chemical, adipic acid [53•].
The high level of control provided by modular type I PKSs is especially useful to generate 
selectively branched biofuels, which is useful to lower the freezing point of fuels and is not 
easily done using FAS. Branching in PKSs occurs through the incorporation of 
methylmalonyl-CoA as a substrate or through S-adenosyl methionine (SAM)-dependent C-
methyltransferases (Figure 3). Non-natural incorporation of AT domains can be pursued 
through AT domain exchanges, AT knockouts with complementation of a trans-AT domain, 
or AT-site directed mutagenesis (reviewed [54]). These methods often degraded the 
specificity of the AT for the alternative substrate, resulting in slower kinetics than the 
original AT domain. Recently, our group identified ‘hot spot’ AT boundaries that can be used 
to swap AT domains while maintaining protein stability and activity (indeed, in some cases, 
improving PKS kinetics) [55]. Methylation through SAM-dependent C-methyltransferases is 
an alternative approach that has not been extensively studied. Recent studies have helped to 
elucidate the reaction mechanism of methyltransferases, indicating that methylation can 
occur before or after Claisen condensation [56,57], and also that excised mono- and di-
methyltransferases can function in vitro [57,58]. This exquisite control over product 
formation could generate customized products with desired combustion properties as biofuel 
substitutes.
Conclusions
The replacement of petroleum-based fuels with renewable fuel sources will only be 
accomplished through higher product yields and lower feedstock costs. As highlighted in 
this review, the production of biofuels (e.g., gasoline, diesel, and jet fuel) lags behind the 
production of substrates (e.g., fatty acids, isoprenoid precursors, malonyl-CoA). To 
transition to a ‘green’ transportation economy, this gap between substrate production and 
biofuel synthesis must be narrowed. While new pathways can be created through the 
discovery and repurposing of enzymatic functions (e.g., ADO in fatty acid synthesis for 
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alkane production), commercial level production of biofuels will not be accomplished until 
we improve enzyme kinetics, toxicity tolerances, and metabolic flux. Improving enzyme 
kinetics usually involves directed evolution or bioprospecting for homologues with more 
appropriate substrate specificity. Directed evolution is frequently difficult because most fuel 
molecules require low throughput assays, limiting library size. Screening for fuel molecules 
in more tolerant microbes has better selection theoretically, but frequently evolving a more 
tolerant microbe to exogenously added fuel does not translate into a better production host 
when the pathway is inserted. Finally improving metabolic flux also suffers from the same 
low throughput assays, limiting library size. While these problems are tractable, solving all 
three concurrently is still difficult and expensive. Given these constraints, developing 
methodologies to make designs more rational and/or developing truly high throughput 
assays has the best potential to move the field forward toward the high titers generally 
needed to make processes attractive for industry to further investigate.
Our opinion is that the diverse fuel energy needs of the global economy may be best served 
by diversifying the metabolic pathways we choose to develop biofuel substitutes. While fatty 
acid synthases may produce the highest titers, the higher energy density of isoprenoids or 
customizability of polyketides may be the best choice to produce tailored biofuel products 
with the desired physical properties. Moreover, the community should leverage the 
versatility of these bioprocesses to search and identify ‘drop-in’ biofuels with superior 
performance.
Acknowledgements
This work was funded by the Joint BioEnergy Institute (JBEI), which is funded by the U.S. Department of Energy, 
Office of Science, Office of Biological and Environmental Research, under Contract DE-AC02-05CH11231, by the 
National Science Foundation under awards MCB-1442724 and NSF-GRFP DGE-1106400, and as part of the Co-
Optimization of Fuels & Engines (Co-Optima) project sponsored by the U. S. Department of Energy (DOE) Office 
of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies and Vehicle Technologies Offices.
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
1. IPCC: Climate Change 2014 Synthesis Report Summary Chapter for Policymakers. IPCC; 2014 
http://dx.doi.org/10.1017/CBO9781107415324.
2. Pacala S: Stabilization wedges: solving the climate problem for the next 50 years with current 
technologies. Science 2004, 305:968–972. [PubMed: 15310891] 
3. Pachauri Rajendra K et al.: Climate Change 2014: Synthesis Report. Contribution of Working 
Groups I, II and III to the Fifth Assessment Report of the Intergovernmental Panel on Climate 
Change. IPCC; 2014.
4. Liao JC, Mi L, Pontrelli S, Luo S: Fuelling the future: microbial engineering for the production of 
sustainable biofuels. Nat. Rev. Microbiol 2016, 14:288–304. [PubMed: 27026253] 
5. Fargione J, Hill J, Tilman D, Polasky S, Hawthorne P: Land clearing and the biofuel carbon debt. 
Sci. J 2008, 319:1235–1237.
6. d’Espaux L, Mendez-Perez D, Li R, Keasling JD: Synthetic biology for microbial production of 
lipid-based biofuels. Curr. Opin. Chem. Biol 2015, 29:58–65. [PubMed: 26479184] 
Zargar et al. Page 7
Curr Opin Biotechnol. Author manuscript; available in PMC 2018 December 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
7. Chen CT, Liao JC: Frontiers in microbial 1-butanol and isobutanol production. FEMS Microbiol. 
Lett 2016, 363.
8. Coursolle D, Lian J, Shanklin J, Zhao H: Production of long chain alcohols and alkanes upon 
coexpression of an acyl-ACP reductase and aldehyde-deformylating oxygenase with a bacterial 
type-I fatty acid synthase in E. coli. Mol. Biosyst 2015, 11:2464–2472. [PubMed: 26135500] 
9. Steen EJ, Kang Y, Bokinsky G, Hu Z, Schirmer A, McClure A, Del Cardayre SB, Keasling JD: 
Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature 2010, 
463:559–562. [PubMed: 20111002] 
10. Mendez-Perez D, Begemann MB, Pfleger BF: Modular synthase-encoding gene involved in α-
olefin biosynthesis in Synechococcus sp. strain PCC 7002. Appl. Environ. Microbiol 2011, 
77:4264–4267. [PubMed: 21531827] 
11. Schirmer A, Rude MA, Li X, Popova E, del Cardayre SB: Microbial biosynthesis of alkanes. 
Science 2010, 329:559–562. [PubMed: 20671186] 
12. Harger M, Zheng L, Moon A, Ager C, An JH, Choe C, Lai Y, Mo B, Zong D, Smith MD et al.: 
Expanding the product profile of a microbial alkane biosynthetic pathway. ACS Synth. Biol 2012, 
2:59–62. [PubMed: 23656326] 
13. Cline PV, Delfino JJ, Rao PSC: Partitioning of aromatic constituents into water from gasoline and 
other complex solvent mixtures. Environ. Sci. Technol 1991, 25:914–920.
14. Youngquist JT, Lennen RM, Ranatunga DR, Bothfeld WH, li WDM, Pfleger BF: Kinetic modeling 
of free fatty acid production in Escherichia coli based on continuous cultivation of a plasmid free 
strain. Biotechnol. Bioeng 2012, 109:1518–1527. [PubMed: 22234725] 
15. Liu T, Vora H, Khosla C: Quantitative analysis and engineering of fatty acid biosynthesis in E. coli. 
Metab. Eng 2010, 12: 378–386. [PubMed: 20184964] 
16. Choi YJ, Lee SY: Microbial production of short-chain alkanes. Nature 2013, 502:571–574. 
[PubMed: 24077097] 
17. Howard TP, Middelhaufe S, Moore K, Edner C, Kolak DM, Taylor GN, Parker DA, Lee R, 
Smirnoff N, Aves SJ et al.: Synthesis of customized petroleum-replica fuel molecules by targeted 
modification of free fatty acid pools in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A 2013, 
110:7636–7641. [PubMed: 23610415] 
18. Liu X, Hicks WM, Silver PA, Way JC: Engineering acyl carrier protein to enhance production of 
shortened fatty acids. Biotechnol. Biofuels 2016, 9:24. [PubMed: 26839587] 
19. Akhtar MK, Turner NJ, Jones PR: Carboxylic acid reductase is a versatile enzyme for the 
conversion of fatty acids into fuels and chemical commodities. Proc. Natl. Acad. Sci. U. S. A 
2013, 110:87–92. [PubMed: 23248280] 
20. Kallio P, Pasztor A, Thiel K, Akhtar MK, Jones PR: An engineered pathway for the biosynthesis of 
renewable propane. Nat. Commun 2014, 5:4731. [PubMed: 25181600] •• In this work, the authors 
for the first time leverage ADO to produce a short-chain hydrocarbon, propane. This is 
accomplished through a heterologous thioesterase from Bacteriodis fragilis, and ADO’s limiting 
catalytic turnover is enhanced through a heterelogous ferredoxin/ferredoxin reductase pair that 
increases electron supply to ADO.
21. Liu H, Yu C, Feng D, Cheng T, Meng X, Liu W, Zou H, Xian M: Production of extracellular fatty 
acid using engineered Escherichia coli. Microb. Cell Fact 2012, 11:41. [PubMed: 22471973] 
22. Xu P, Gu Q, Wang W, Wong L, Bower AGW, Collins CH, Koffas MAG: Modular optimization of 
multi-gene pathways for fatty acids production in E. coli. Nat. Commun 2013, 4:1409. [PubMed: 
23361000] 
23. Haushalter RW, Groff D, Deutsch S, The L, Chavkin TA, Brunner SF, Katz L, Keasling JD: 
Development of an orthogonal fatty acid biosynthesis system in E. coli for oleochemical 
production. Metab. Eng 2015, 30:1–6. [PubMed: 25887638] • Heterologous Type I FAS’s from 
multiple species were expressed in E. coli, and the Corynebacterium glutamicum FAS was applied 
to produce fatty alcohols and methyl ketones. While the titer is lower than native FAS, further 
improvements could improve yield as this pathway directly produces acyl-CoAs without an acyl 
ligase.
24. Eser BE, Das D, Han J, Jones PR, Marsh ENG: Oxygen-independent alkane formation by non-
heme iron-dependent cyanobacterial aldehyde decarbonylase: investigation of kinetics and 
Zargar et al. Page 8
Curr Opin Biotechnol. Author manuscript; available in PMC 2018 December 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
requirement for an external electron donor. Biochemistry 2011, 50:10743–10750. [PubMed: 
22074177] 
25. Rodriguez GM, Atsumi S: Toward aldehyde and alkane production by removing aldehyde 
reductase activity in Escherichia coli. Metab. Eng 2014, 25:227–237. [PubMed: 25108218] 
26. Sheppard MJ, Kunjapur AM, Prather KLJ: Modular and selective biosynthesis of gasoline-range 
alkanes. Metab. Eng 2016, 33:28–40. [PubMed: 26556131] 
27. Cao Y, Xiao W-H, Zhang J-L, Xie Z-X, Ding M-Z, Yuan Y-J: Heterologous biosynthesis and 
manipulation of alkanes in Escherichia coli. Metab. Eng 2016, 38:19–28. [PubMed: 27267408] •• 
Recent work that advances a pathway synergy between ADO and AHR, where increased titer of 
ADO is produced when AHR is moderately enhanced.
28. Li N, Chang WC, Warui DM, Booker SJ, Krebs C, Bollinger JM: Evidence for only oxygenative 
cleavage of aldehydes to alk(a/e)nes and formate by cyanobacterial aldehyde decarbonylases. 
Biochemistry 2012, 51:7908–7916. [PubMed: 22947199] 
29. Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD: Engineering a mevalonate pathway 
in Escherichia coli for production of terpenoids. Nat. Biotechnol 2003, 21:796–802. [PubMed: 
12778056] 
30. Pitera DJ, Paddon CJ, Newman JD, Keasling JD: Balancing a heterologous mevalonate pathway 
for improved isoprenoid production in Escherichia coli. Metab. Eng 2007, 9:193–207. [PubMed: 
17239639] 
31. Millo F, Bensaid S, Fino D, Marcano SJC, Vlachos T, Debnath BK: Influence on the performance 
and emissions of an automotive Euro 5 diesel engine fueled with F30 from farnesane. Fuel 2014, 
138:134–142.
32. Peralta-Yahya PP, Ouellet M, Chan R, Mukhopadhyay A, Keasling JD, Lee TS: Identification and 
microbial production of a terpene-based advanced biofuel. Nat. Commun 2011, 2:483. [PubMed: 
21952217] 
33. Özaydin B, Burd H, Lee TS, Keasling JD: Carotenoid-based phenotypic screen of the yeast 
deletion collection reveals new genes with roles in isoprenoid production. Metab. Eng 2013, 
15:174–183. [PubMed: 22918085] 
34. Phelan RM, Sekurova ON, Keasling JD, Zotchev SB: Engineering terpene biosynthesis in 
Streptomyces for production of the advanced biofuel precursor bisabolene. ACS Synth. Biol 2015, 
4:393–399. [PubMed: 25006988] 
35. Tippmann S, Scalcinati G, Siewers V, Nielsen J: Production of farnesene and santalene by 
Saccharomyces cerevisiae using fed-batch cultivations with RQ-controlled feed. Biotechnol. 
Bioeng 2016, 113:72–81. [PubMed: 26108688] 
36. Zhu F, Zhong X, Hu M, Lu L, Deng Z, Liu T: In vitro reconstitution of mevalonate pathway and 
targeted engineering of farnesene overproduction in Escherichia coli. Biotechnol. Bioeng 2014, 
111:1396–1405. [PubMed: 24473754] • Through the full reconstituion of the mevalonate pathway, 
this group determined the isopentyl diphosphate isomerase (Idi) to be rate-limiting, and its 
overexpression resulted in a fivefold increase. The reconstitution method applied here is general, 
and could be very effective for the optimized production of other terpenoids.
37. Amyris: Amyris achieves record low cost farnesene production. 2015 URL: https://amyris.com/
amyris-achieves-record-low-cost-farnesene-production/.
38. Harvey BG, Wright ME, Quintana RL: High-density renewable fuels based on the selective 
dimerization of pinenes. Energy Fuels 2010, 24:267–273.
39. Yang J, Nie Q, Ren M, Feng H, Jiang X, Zheng Y, Liu M, Zhang H, Xian M: Metabolic 
engineering of Escherichia coli for the biosynthesis of alpha-pinene. Biotechnol. Biofuels 2013, 
6:60. [PubMed: 23631625] 
40. Sarria S, Wong B, Martín H, Keasling J, Peralta-Yahya P: Microbial synthesis of pinene. ACS 
Synth. Biol 2014, 3:466–475. [PubMed: 24679043] 
41. Tomko TA, Dunlop MJ: Engineering improved bio-jet fuel tolerance in Escherichia coli using a 
transgenic library from the hydrocarbon-degrader Marinobacter aquaeolei. Biotechnol. Biofuels 
2015, 8:165. [PubMed: 26448785] 
42. Ryder JA: Jet fuel compositions and methods of making and using same. United States Pat. 2012, 
US8106247.
Zargar et al. Page 9
Curr Opin Biotechnol. Author manuscript; available in PMC 2018 December 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
43. Alonso-Gutierrez J, Chan R, Batth TS, Adams PD, Keasling JD, Petzold CJ, Lee TS: Metabolic 
engineering of Escherichia coli for limonene and perillyl alcohol production. Metab. Eng 2013, 
19:33–41. [PubMed: 23727191] 
44. Carter OA, Peters RJ, Croteau R: Monoterpene biosynthesis pathway construction in Escherichia 
coli. Phytochemistry 2003, 64:425–433. [PubMed: 12943759] 
45. Chubukov V, Mingardon F, Schackwitz W, Baidoo EEK, Alonso-Gutierrez J, Hu Q, Lee TS, 
Keasling JD, Mukhopadhyay A: Acute limonene toxicity in Escherichia coli is caused by limonene 
hydroperoxide and alleviated by a point mutation in alkyl hydroperoxidase AhpC. Appl. Environ. 
Microbiol 2015, 81:4690–4696. [PubMed: 25934627] 
46. Brennan TCR, Turner CD, Krömer JO, Nielsen LK: Alleviating monoterpene toxicity using a two-
phase extractive fermentation for the bioproduction of jet fuel mixtures in Saccharomyces 
cerevisiae. Biotechnol. Bioeng 2012, 109: 2513–2522. [PubMed: 22539043] 
47. Kung Y, McAndrew RP, Xie X, Liu CC, Pereira JH, Adams PD, Keasling JD: Constructing tailored 
isoprenoid products by structure-guided modification of geranylgeranyl reductase. Structure 2014, 
22:1028–1036. [PubMed: 24954619] •• Here, the authors show the crystallized structure of a 
geranylgeranyl reductase (GGR) that hydrogenates carbon–carbon double bonds as part of its cell 
membrane synthesis pathway. Targeted mutations increased hydrogenation kinetics, and the 
authors speculate that GGR could be especially useful for isoprenoid-based biofuels.
48. Pieper R, Ebert-Khosla S, Cane D, Khosla C: Erythromycin biosynthesis: kinetic studies on a fully 
active modular polyketide synthase using natural and unnatural substrates. Biochemistry 1996, 
35:2054–2060. [PubMed: 8652546] 
49. Smith S, Tsai S-C: The type I fatty acid and polyketide synthases: a tale of two megasynthases. 
Nat. Prod. Rep 2007, 24:1041–1072. [PubMed: 17898897] 
50. Garg A, Xie X, Keatinge-Clay A, Khosla C, Cane DE: Elucidation of the cryptic epimerase activity 
of redox-inactive ketoreductase domains from modular polyketide synthases by tandem 
equilibrium isotope exchange. J. Am. Chem. Soc 2014, 136:10190–10193. [PubMed: 25004372] 
51. Menendez-Bravo S, Comba S, Sabatini M, Arabolaza A, Gramajo H: Expanding the chemical 
diversity of natural esters by engineering a polyketide-derived pathway into Escherichia coli. 
Metab. Eng 2014, 24:97–106. [PubMed: 24831705] 
52. Liu Q, Wu K, Cheng Y, Lu L, Xiao E, Zhang Y, Deng Z, Liu T: Engineering an iterative polyketide 
pathway in Escherichia coli results in single-form alkene and alkane overproduction. Metab. Eng 
2015, 28:82–90. [PubMed: 25536488] • Through a reconsitution of the iterative PKS SgcE, the 
authors determined optimized balance of the PKS with its thioesterase by refactoring its 
promoters.
53. Hagen A, Poust S, Rond de T, Fortman JL, Katz L, Petzold CJ, Keasling JD: Engineering a 
polyketide synthase for in vitro production of adipic acid. ACS Synth. Biol 2016, 5:21–27. 
[PubMed: 26501439] • In this work, the authors swap in the full reducing domains of foreign 
PKS’s into the borreledin PKS to produce adipic acid. Importantly, the authors show that by 
removal of the thioesterase, the “Ppant ejection assay” can be used to identify and relieve 
bottlenecks.
54. Dunn BJ, Khosla C: Engineering the acyltransferase substrate specificity of assembly line 
polyketide synthases. J. R. Soc. Interface 2013, 10:20130297. [PubMed: 23720536] 
55. Yuzawa S, Deng K, Wang G, Baidoo EEK, Northen TR, Adams PD, Katz L, Keasling JD: 
Comprehensive in vitro analysis of acyltransferase domain exchanges in modular polyketide 
synthases and its application for short-chain ketone production. ACS Synth. Biol 2016, 6(1):139–
147 http://dx.doi.org/10.1021/acssynbio.6b00176. [PubMed: 27548700] 
56. Poust S, Phelan RM, Deng K, Katz L, Petzold CJ, Keasling JD: Divergent mechanistic routes for 
the formation of gem-dimethyl groups in the biosynthesis of complex polyketides. Angew. Chem. 
Int. Ed. Engl 2015, 54:2370–2373. [PubMed: 25564997] 
57. Wagner DT, Stevens DC, Mehaffey MR, Manion HR, Taylor RE, Brodbelt JS, Keatinge-Clay AT: 
α-Methylation follows condensation in the gephyronic acid modular polyketide synthase. Chem. 
Commun 2016, 52(57):8822–8825 http://dx.doi.org/10.1039/C6CC04418B.
58. Stevens DC, Wagner DT, Manion HR, Alexander BK, Keatinge-Clay AT: Methyltransferases 
excised from trans-AT polyketide synthases operate on N-acetylcysteamine-bound substrates. J. 
Antibiot 2016, 69(7):567–570 http://dx.doi.org/10.1038/ja.2016.66. [PubMed: 27301661] 
Zargar et al. Page 10
Curr Opin Biotechnol. Author manuscript; available in PMC 2018 December 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Fatty acid synthesis of alkanes. (a) In the first step of fatty acid synthesis, acetyl-CoA and 
malonyl-CoA are transthioesterified to the fatty acid synthase (FAS), and the final product of 
each round of elongation is a fatty-acyl ACP. A thioesterase (TesA) can cleave the fatty-acyl 
ACP to generate a free fatty acid that reacts with an acyl-CoA ligase (ACL) to generate 
fatty-acyl CoA. (b) Fatty aldehydes can be generated from fatty-acyl ACP, free fatty acids, 
and fatty-acyl CoA through acyl carrier protein reductase (AAR), carboxylic acid reductase 
(CAR), and acyl CoA reductase (ACR1), respectively. (c) Fatty aldehydes can generate 
alkanes through aldehyde decarbonylase (ADO) and fatty alcohols through aldehyde 
reductase (AHR).
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Figure 2. 
Isoprenoid pathway for the production of biobased diesel and jet fuels. (a) Acetyl-CoA 
generates the building blocks for isoprenoid production through the mevalonate pathway. (b) 
Farenyl pyrophosphate synthase (FPPS) synthesizes feranyl pyrophosphate (FPP) from two 
IPP and one DMAPP. Farnesene and bisabolene are synthesized by their respective 
synthases from FPP. Hydrogenation of each molecule produces biodiesel fuel candidates. (c) 
Geranyl pyrophosphate synthase (GPPS), converts an IPP and DMAPP molecule to geranyl 
pyrophosphate (GPP). Limonene and pinene are synthesized by limonene and pinene 
synthase, respectively. Chemically dimerized pinene and hydrogenated limonene are 
biobased jet fuel candidates.
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Figure 3. 
Branching through polyketide synthase pathways. (a) An acyltransferase (AT, highlighted in 
red) selects for methylmalonyl-CoA and transfers it to a phosphopantetheine arm of the acyl 
carrier protein (ACP). A Claisen condensation reaction of methyl-malonate and the primer 
chain takes place at the ketosynthase (KS), resulting in a α-methyl group (red). The ACP 
then shuttles the resulting ketone through the processing domains that reduce (ketoreductase, 
KR) and dehydrate (dehydratase, DH) the β-ketone, where the enoyl reductase (ER) full 
reduces the keto group. (b) An alternative approach to generating a α-branched carbon (red) 
is through utilizing SAM-dependent methyl transferases (MT, highlighted in red).
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